4uu9: Difference between revisions
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Crystal structure of the human c5a in complex with MEDI7814 a neutralising antibody== | ==Crystal structure of the human c5a in complex with MEDI7814 a neutralising antibody== | ||
<StructureSection load='4uu9' size='340' side='right' caption='[[4uu9]], [[Resolution|resolution]] 2.12Å' scene=''> | <StructureSection load='4uu9' size='340' side='right'caption='[[4uu9]], [[Resolution|resolution]] 2.12Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4uu9]] is a 6 chain structure with sequence from [ | <table><tr><td colspan='2'>[[4uu9]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4UU9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4UU9 FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.12Å</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4uu9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4uu9 OCA], [https://pdbe.org/4uu9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4uu9 RCSB], [https://www.ebi.ac.uk/pdbsum/4uu9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4uu9 ProSAT]</span></td></tr> | |||
</table> | </table> | ||
== Disease == | == Disease == | ||
[ | [https://www.uniprot.org/uniprot/CO5_HUMAN CO5_HUMAN] Defects in C5 are the cause of complement component 5 deficiency (C5D) [MIM:[https://omim.org/entry/609536 609536]. A rare defect of the complement classical pathway associated with susceptibility to severe recurrent infections, predominantly by Neisseria gonorrhoeae or Neisseria meningitidis. Note=An association study of C5 haplotypes and genotypes in individuals with chronic hepatitis C virus infection shows that individuals homozygous for the C5_1 haplotype have a significantly higher stage of liver fibrosis than individuals carrying at least 1 other allele (PubMed:15995705). | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/CO5_HUMAN CO5_HUMAN] Activation of C5 by a C5 convertase initiates the spontaneous assembly of the late complement components, C5-C9, into the membrane attack complex. C5b has a transient binding site for C6. The C5b-C6 complex is the foundation upon which the lytic complex is assembled. Derived from proteolytic degradation of complement C5, C5 anaphylatoxin is a mediator of local inflammatory process. It induces the contraction of smooth muscle, increases vascular permeability and causes histamine release from mast cells and basophilic leukocytes. C5a also stimulates the locomotion of polymorphonuclear leukocytes (chemokinesis) and direct their migration toward sites of inflammation (chemotaxis). | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 20: | Line 21: | ||
</div> | </div> | ||
<div class="pdbe-citations 4uu9" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 4uu9" style="background-color:#fffaf0;"></div> | ||
==See Also== | |||
*[[Complement C5 3D structures|Complement C5 3D structures]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Homo sapiens]] | ||
[[Category: Bonnell | [[Category: Large Structures]] | ||
[[Category: Brennan | [[Category: An Eghobamien L]] | ||
[[Category: Colley | [[Category: Bonnell J]] | ||
[[Category: Davies | [[Category: Brennan J]] | ||
[[Category: Debreczeni | [[Category: Colley C]] | ||
[[Category: Dobson | [[Category: Davies R]] | ||
[[Category: Edwards | [[Category: Debreczeni JE]] | ||
[[Category: Dobson C]] | |||
[[Category: England | [[Category: Edwards B]] | ||
[[Category: Flavell | [[Category: England L]] | ||
[[Category: Fung | [[Category: Flavell L]] | ||
[[Category: Hargreaves | [[Category: Fung S]] | ||
[[Category: Howes | [[Category: Hargreaves D]] | ||
[[Category: Popovic | [[Category: Howes R]] | ||
[[Category: Renshaw | [[Category: Popovic B]] | ||
[[Category: Sivars | [[Category: Renshaw GJ]] | ||
[[Category: Sridharan | [[Category: Sivars U]] | ||
[[Category: Vaughan | [[Category: Sridharan S]] | ||
[[Category: Warrener | [[Category: Vaughan T]] | ||
[[Category: Wickson | [[Category: Warrener P]] | ||
[[Category: Wilkinson | [[Category: Wickson K]] | ||
[[Category: Woods | [[Category: Wilkinson T]] | ||
[[Category: Woods R]] | |||